Effects of Argatroban on Hcy, hs-CRP and FIB levels in patients with acute cerebral infarction

References

• Liang Y, Wu J, Liu J, et al. The clinical implications of thrombelastography in the diagnosis of acute cerebral infarction. Clin Lab. 2018;64(1):147–152. doi: 10.7754/Clin.Lab.2017.170803.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Nakajima H, Kimura F, et al. Preventive effect of cilostazol on pneumonia in patients with acute cerebral infarction. J Stroke Cerebrovasc Dis. 2018;27(9):2354–2359. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.024.
   PubMed Web of Science ®Google Scholar
• Arboix A, Alio J. Acute cardioembolic cerebral infarction: answers to clinical questions. Curr Cardiol Rev. 2012;8(1):54–67. doi: 10.2174/157340312801215791.
   PubMedGoogle Scholar
• Yan Z, Fu B, He D, et al. The relationship between oxidized low-density lipoprotein and related ratio and acute cerebral infarction. Medicine. 2018;97(39):e12642. doi: 10.1097/MD.0000000000012642.
   PubMed Web of Science ®Google Scholar
• NanZhu Y, AiChun J, Xin L, et al. Salvianolate injection in the treatment of acute cerebral infarction: a systematic review and a meta-analysis. Medicine. 2018;97(47):e12374. doi: 10.1097/MD.0000000000012374.
   PubMed Web of Science ®Google Scholar
• Shen GX. Inhibition of thrombin: relevance to anti-thrombosis strategy. Front Biosci. 2006;11(1):113–120. doi: 10.2741/1783.
   PubMedGoogle Scholar
• Suzuki H, Tsunematsu T, Takahashi H, et al. A case of heparin-induced thrombocytopenia with subacute stent thrombosis, multiple cerebral infarction, and acute limb ischemia. J Cardiol Cases. 2017;15(5):145–149. doi: 10.1016/j.jccase.2016.12.013.
   PubMedGoogle Scholar
• Zhang SG. Research progress and evaluation on clinical application of direct thrombin inhibitor. Eval Anal Drug-Use Hosp China. 2013;13(7):586–590.
   Google Scholar
• Walenga JM. An overview of the direct thrombin inhibitor argatroban. Pathophysiol Haemost Thromb. 2002;32(Suppl. 3):9–14. doi: 10.1159/000069103.
   PubMedGoogle Scholar
• Wang YH, OuYang CX, Zhou M, et al. Clinical application and monitoring methods of argatroban. Chin J Clin. 2010;4(4):467–470.
   Google Scholar
• Al-Salihi MM, Saha R, Ayyad A, et al. Efficacy and safety of argatroban in the management of acute ischemic stroke: a systematic literature review and meta-analysis. Clin Neurol Neurosurg. 2024;236:108097. doi: 10.1016/j.clineuro.2023.108097.
   PubMed Web of Science ®Google Scholar
• Bea F, Kreuzer J, Preusch M, et al. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26(12):2787–2792. doi: 10.1161/01.ATV.0000246797.05781.ad.
   PubMed Web of Science ®Google Scholar
• Chen JL. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications. Heart Dis. 2001;3(3):189–198.
   PubMedGoogle Scholar
• Jansen van Vuuren J, Pillay S, Naidoo A. Circulating biomarkers in long-term stroke prognosis: a scoping review focusing on the South African setting. Cureus. 2022;14(4):e23971. doi: 10.7759/cureus.23971.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Kam CH, Ritter VS, et al. Diagnostic accuracy of acute infarcts in multiple cerebral circulations for cardioembolic stroke: literature review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(7):104849. doi: 10.1016/j.jstrokecerebrovasdis.2020.104849.
   PubMed Web of Science ®Google Scholar
• Zhao XJ, Li QX, Liu TJ, et al. Predictive values of CSS and NIHSS in the prognosis of patients with acute cerebral infarction: a comparative analysis. Medicine. 2018;97(39):e12419. doi: 10.1097/MD.0000000000012419.
   PubMed Web of Science ®Google Scholar
• Li F, Chen QX, Peng B, et al. Microalbuminuria in patients with acute ischemic stroke. Neurol Res. 2019;41(6):498–503.
   PubMed Web of Science ®Google Scholar
• Chalos V, van der Ende NAM, Lingsma HF, et al. National institutes of health stroke scale: an alternative primary outcome measure for trials of acute treatment for ischemic stroke. Stroke. 2020;51(1):282–290. doi: 10.1161/STROKEAHA.119.026791.
   PubMed Web of Science ®Google Scholar
• Li QX, Zhao XJ, Wang Y, et al. Value of the Barthel scale in prognostic prediction for patients with cerebral infarction. BMC Cardiovasc Disord. 2020;20(1):14. doi: 10.1186/s12872-019-01306-1.
   PubMed Web of Science ®Google Scholar
• Rech KD, Salazar AP, Marchese RR, et al. Fugl-Meyer assessment scores are related with kinematic measures in people with chronic hemiparesis after stroke. J Stroke Cerebrovasc Dis. 2020;29(1):104463. doi: 10.1016/j.jstrokecerebrovasdis.2019.104463.
   PubMed Web of Science ®Google Scholar
• Buonacera A, Stancanelli B, Malatino L. Stroke and hypertension: an appraisal from pathophysiology to clinical practice. Curr Vasc Pharmacol. 2019;17(1):72–84. doi: 10.2174/1570161115666171116151051.
   PubMed Web of Science ®Google Scholar
• Šaňák D, Jakubíček S, Černík D, et al. Intravenous thrombolysis in patients with acute ischemic stroke after a reversal of dabigatran anticoagulation with idarucizumab: a real-world clinical experience. J Stroke Cerebrovasc Dis. 2018;27(9):2479–2483. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.004.
   PubMed Web of Science ®Google Scholar
• Serebruany MV, Malinin AI, Serebruany VL. Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives. Expert Opin Pharmacother. 2006;7(1):81–89. doi: 10.1517/14656566.7.1.81.
   PubMed Web of Science ®Google Scholar
• Chen S, Cai D, Huang P, et al. Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke. Clin Neurol Neurosurg. 2020;198:106233. doi: 10.1016/j.clineuro.2020.106233.
   PubMed Web of Science ®Google Scholar
• Chen L, Cao S, Yang J. Argatroban plus aspirin versus aspirin in acute ischemic stroke. Neurol Res. 2018;40(10):862–867. doi: 10.1080/01616412.2018.1495882.
   PubMed Web of Science ®Google Scholar
• Nishi R, Mano T, Kobayashi Y, et al. Argatroban, aspirin, and clopidogrel combination therapy for acute penetrating artery infarction: a pilot study. Brain Nerve. 2016;68(2):181–189. doi: 10.11477/mf.1416200370.
   PubMedGoogle Scholar
• Qin LZ, Li W, Huang Y, et al. PTX3 expression in the plasma of elderly ACI patients and its relationship with severity and prognosis of the disease. Eur Rev Med Pharmacol Sci. 2016;20(19):4112–4118.
   PubMed Web of Science ®Google Scholar
• Oguro H, Mitaki S, Takayoshi H, et al. Retrospective analysis of argatroban in 353 patients with acute noncardioembolic stroke. J Stroke Cerebrovasc Dis. 2018;27(8):2175–2181. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.016.
   PubMed Web of Science ®Google Scholar
• Deeds SI, Barreto A, Elm J, et al. The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: rationale and methods. Int J Stroke. 2021;16(7):873–880. doi: 10.1177/1747493020978345.
   PubMed Web of Science ®Google Scholar